Molecular Screening Services
This Prior Information Notice (PIN) is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of an up-and-coming tender opportunity. NHSBT are looking for a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can detect HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA in EDTA plasma from blood and non-blood (e.g. stem cell, tissue) donors including from deceased (non-heart beating) donors. The solutio...
Buyer
NHS Blood and Transplant
Value
£3,800,000
Published
17 Mar 2023
Closes
17 Mar 2023
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33124130
Diagnostic supplies
71900000
Laboratory services
48921000
Automation system
33696500
Laboratory reagents
33141625
Diagnostic kits
33124110
Diagnostic systems
33140000
Medical consumables
33124000
Diagnostics and radiodiagnostic devices and supplies
Lots
Lot 1 Molecular Screening Services
Value not provided
NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.